OCT
What it found
No result yet.
What was tested
Treatment tested
- Glatiramer acetate
Unknown
What it measured
Main measures
• Feasibility of OCT measurement in patient with CIS other than ON or with early RRMS in the Dutch clinical setting.
Retina scans (OCT)Feasibility
Who could take part
Relapsing MS
Inclusion: • Age: 18 – 45 years Exclusion: • Clinical definite multiple sclerosis (CDMS) with a disease course more than 3 years
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
To assess the feasibility of optical coherence tomography (OCT) measurement in patient with CIS other than optic neuritis (ON) or in patients with early MS in the Dutch clinical setting by qualitative evaluation
Loading reviews and guidelines…
Related trials
- TWINS
Phase 3 · Not yet recruiting
Still running
- AIOLOS
Recruiting
Still running
- Full Responders
Phase 4 · Stopped early
Stopped early
- A Study to Learn More About The Safety of Diroximel Fumar…
Running, not recruiting
Still running
- A Open-label Study to Assess Response to COVID-19 Vaccine…
Phase 4 · Stopped early
Stopped: safety
- A Study to Asses Efficacy, Safety and Tolerability of Mon…
Phase 3 · Completed
Met its main goal
History
Started
Jun 2009
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error